Bone regenerative medicine using allogeneic bone marrow derived mesenchymal stem cells secretome

Bone regenerative medicine using allogeneic bone marrow derived mesenchymal stem cells secretome - Bone regeneration using allogenic secretomes

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011290

Enrollment

Registered

2013-07-27

Start date

2013-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone defect due to removal of teeth, Periodontitis

Interventions

MSC-CM Group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with bone defect due to removal of teeth Patients with periodontal pockets (over 4mm) after initial periodontal therapy

Exclusion criteria

Exclusion criteria: Patients who have contraindications for any surgery Patients who have bone metabolic diseases such as osteoporosis, diabetes and neoplasms Patients who are or were receiving bisphosphonate therapy Patients who are pregnant, suspected pregnant and brest-feeding. Patients who have allergie for anesthetic and antibiotics Patients who have infectious disease

Design outcomes

Primary

Measure	Time frame
No complications and side effects will be reported throughout the study	—

Secondary

Measure	Time frame
Bone regeneration will be seen in X-ray 6 months after application	—

Countries

Japan

Contacts

Public ContactWataru Katagiri

Nagoya University Hospital Oral and Maxillofacial Surgery

w-kat@med.nagoya-u.ac.jp052-744-2348

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026